Paper25758331
Light-controlled endosomal escape of the novel CD133-targeting immunotoxin AC133-saporin by photochemical internalization - A minimally invasive cancer stem cell-targeting strategy.
Bostad M and 5 others. J Control Release, 2015. Cited by 56 papers, by iCite.
Cite this record
ConductScience Library. Light-controlled endosomal escape of the novel CD133-targeting immunotoxin AC133-saporin by photochemical internalization - A minimally invasive cancer stem cell-targeting strategy. Papers, record 25758331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25758331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Light-controlled endosomal escape of the novel CD133-targeting immunotoxin AC133-saporin by photochemical internalization - A minimally invasive cancer stem cell-targeting strategy.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenocarcinoma | Major topic |
| Colorectal Neoplasms | Major topic |
| Immunotoxins | Major topic |
| Photosensitizing Agents | Major topic |
| Ribosome Inactivating Proteins, Type 1 | Major topic |
| Cell Line, Tumor | |
| Colon | |
| Drug Delivery Systems | |
| Endosomes | |
| Humans | |
| Light | |
| Neoplastic Stem Cells | |
| Photochemotherapy | |
| Rectum | |
| Saporins |
Source PubMed
Cited by31
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 56 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41976384 | Photodynamic Therapy-Based Strategies Targeted at Cancer Stem Cells: A Scoping Review. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41976384 | PubMed |
| 39238997 | Concise review: breast cancer stems cells and their role in metastases. | Ann Med Surg (Lond) | 2024 | https://conductscience.org/library/papers/39238997 | PubMed |
| 39199632 | Unveiling the Dynamic Interplay between Cancer Stem Cells and the Tumor Microenvironment in Melanoma: Implications for Novel Therapeutic Strategies. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39199632 | PubMed |
| 38612911 | Informed by Cancer Stem Cells of Solid Tumors: Advances in Treatments Targeting Tumor-Promoting Factors and Pathways. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38612911 | PubMed |
| 38609981 | Nanobiotechnology augmented cancer stem cell guided management of cancer: liquid-biopsy, imaging, and treatment. | J Nanobiotechnology | 2024 | https://conductscience.org/library/papers/38609981 | PubMed |
| 37997289 | The Interaction between Collagen 1 and High Mannose Type CD133 Up-Regulates Glutamine Transporter SLC1A5 to Promote the Tumorigenesis of Glioblastoma Stem Cells. | Adv Sci (Weinh) | 2024 | https://conductscience.org/library/papers/37997289 | PubMed |
| 36839918 | Lipopolyplex-Mediated Co-Delivery of Doxorubicin and FAK siRNA to Enhance Therapeutic Efficiency of Treating Colorectal Cancer. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/36839918 | PubMed |
| 36650239 | Tumor-specific intracellular delivery: peptide-guided transport of a catalytic toxin. | Commun Biol | 2023 | https://conductscience.org/library/papers/36650239 | PubMed |
| 36046046 | Fate decisions of breast cancer stem cells in cancer progression. | Front Oncol | 2022 | https://conductscience.org/library/papers/36046046 | PubMed |
| 35481195 | Gold nanoparticles conjugated with anti-CD133 monoclonal antibody and 5-fluorouracil chemotherapeutic agent as nanocarriers for cancer cell targeting. | RSC Adv | 2021 | https://conductscience.org/library/papers/35481195 | PubMed |
| 34829955 | Antibody-Based Immunotoxins for Colorectal Cancer Therapy. | Biomedicines | 2021 | https://conductscience.org/library/papers/34829955 | PubMed |
| 34204611 | Efficacy and Selectivity of FGF2-Saporin Cytosolically Delivered by PCI in Cells Overexpressing FGFR1. | Cells | 2021 | https://conductscience.org/library/papers/34204611 | PubMed |
| 32256588 | Saponin Facilitates Anti-Robo1 Immunotoxin Cytotoxic Effects on Maxillary Sinus Squamous Cell Carcinoma. | J Oncol | 2020 | https://conductscience.org/library/papers/32256588 | PubMed |
| 32215748 | Application of the Tumor Site Recognizable and Dual-Responsive Nanoparticles for Combinational Treatment of the Drug-Resistant Colorectal Cancer. | Pharm Res | 2020 | https://conductscience.org/library/papers/32215748 | PubMed |
| 31936595 | Photochemical Internalization: Light Paves Way for New Cancer Chemotherapies and Vaccines. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/31936595 | PubMed |
| 31888091 | Design, Characterization, and Evaluation of scFvCD133/rGelonin: A CD133-Targeting Recombinant Immunotoxin for Use in Combination with Photochemical Internalization. | J Clin Med | 2019 | https://conductscience.org/library/papers/31888091 | PubMed |
| 31275378 | Production and Evaluation of an Avian IgY Immunotoxin against CD133+ for Treatment of Carcinogenic Stem Cells in Malignant Glioma: IgY Immunotoxin for the Treatment of Glioblastoma. | J Oncol | 2019 | https://conductscience.org/library/papers/31275378 | PubMed |
| 29565434 | Enhanced targeting of triple-negative breast carcinoma and malignant melanoma by photochemical internalization of CSPG4-targeting immunotoxins. | Photochem Photobiol Sci | 2018 | https://conductscience.org/library/papers/29565434 | PubMed |
| 29476201 | Pharmacological targets of breast cancer stem cells: a review. | Naunyn Schmiedebergs Arch Pharmacol | 2018 | https://conductscience.org/library/papers/29476201 | PubMed |
| 29438358 | Strategies to Improve the Clinical Utility of Saporin-Based Targeted Toxins. | Toxins (Basel) | 2018 | https://conductscience.org/library/papers/29438358 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CASP3 | 836 | PubTator's text mining | https://conductscience.org/library/genes/836 | NCBI Gene |
| PARP1 | 142 | PubTator's text mining | https://conductscience.org/library/genes/142 | NCBI Gene |
| PROM1 | 8842 | PubTator's text mining | https://conductscience.org/library/genes/8842 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25758331
GET https://conductscience.org/api/papers/v1/25758331/cited_by?page=2